Injectable anti-obesity drugs shown to benefit heart health

Injectable weight loss drugs can improve heart health

A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, and how lifestyle interventions for weight loss affect heart biomarkers in diabetics.

Continue Reading

Category: Heart Disease, Illnesses and conditions, Body & Mind

Tags: , , ,

Leave a comment
Stay up to date
Register now to get updates on promotions and coupons
Optimized by OptimoleThe owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.

Shopping cart

×